However, the Y30 extract did not significantly affect viral HA, NA, and RdRp activities, suggesting that the anti-influenza compounds in the Y30 extract inhibit influenza A virus infection and growth by targeting other viral or host factors for viral assembly and/or release in the host cells. Here, XK is linked to influenza.